MAb biosimilars for solid tumours: Perspectives for pharmacists
touchEXPERT OPINIONS for touchONCOLOGY
Listen to leading experts discuss how monoclonal antibody (MAb) biosimilars for solid tumours are developed and approved, and learn about the practical aspects of their use in oncology pharmacy.
The experts
Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK
Dr Joseph Bubalo - Oregon Health & Science University Hospital & Clinics, Portland, USA
Mr Hisanaga Nomura - Japan Agency for Medical Research and Development, Tokyo, Japan
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.